about
Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study)General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 CohortA Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 StudyAge at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million peopleDistinct trajectories of HbA1c in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approach
P50
description
researcher (ORCID 0000-0001-7804-1740)
@en
wetenschapper
@nl
name
Wolfgang Rathmann
@en
Wolfgang Rathmann
@nl
type
label
Wolfgang Rathmann
@en
Wolfgang Rathmann
@nl
prefLabel
Wolfgang Rathmann
@en
Wolfgang Rathmann
@nl
P31
P496
0000-0001-7804-1740